| Followers | 132 |
| Posts | 6436 |
| Boards Moderated | 0 |
| Alias Born | 10/25/2011 |
Friday, December 29, 2023 1:40:09 PM
$SHMN: Mike: The law of averages, Probability based on evidence, states that the company has turned a corner!
If we had to speculate [about why the vapor ware tweets & PRs last year], I would say that, Barron tried to sell Rx products W/O
producing them in the States. [BTW:-The 3rd party MFR, in the States adds too much to the cost of doing business].
No distributor wants to risk lawsuits.
Some countries in eastern EU & India have some major FDA Inspected facilities.
However, they are also linked with major Pharmas like Astrazeneca etc.
So Barron was probably unsuccessful in the process of obtaining POs last year.
But it's a NEW Ball Game & the Company is well positioned [Methinks they're already shipping some product].
And like Traderguy stated....The probable business relationship with Universal SEQ [which has Illumina as a customer]; will be very beneficial to $SHMN's S/Hs, as far as ABBIE is concerned!
If we had to speculate [about why the vapor ware tweets & PRs last year], I would say that, Barron tried to sell Rx products W/O
producing them in the States. [BTW:-The 3rd party MFR, in the States adds too much to the cost of doing business].
No distributor wants to risk lawsuits.
Some countries in eastern EU & India have some major FDA Inspected facilities.
However, they are also linked with major Pharmas like Astrazeneca etc.
So Barron was probably unsuccessful in the process of obtaining POs last year.
But it's a NEW Ball Game & the Company is well positioned [Methinks they're already shipping some product].
And like Traderguy stated....The probable business relationship with Universal SEQ [which has Illumina as a customer]; will be very beneficial to $SHMN's S/Hs, as far as ABBIE is concerned!
Bullish
Throw me to the WOLVES.......and I shall return LEADING THE PACK!
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
